Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sarepta Therapeutics granted inducement equity awards to 30 individuals hired during the second quarter of 2026. The awards consist of an aggregate of 151,305 restricted stock units, approved by the Compensation Committee under Nasdaq Listing Rule 5635(c)(4).
Key figures
- Shares Offered
- 151305
- Recipients count
- 30
- Vesting term years
- 4
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.